* OptiNose Inc OPTN.OQ OPTN.O is expected to show a fall
in
quarterly revenue when it reports results on March 7.
* The Yardley Pennsylvania-based company is expected to
report a
8.1% decrease in revenue to $20.688 million from $22.51 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for OptiNose Inc is for
a
loss of 17 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for OptiNose
Inc is
$4.5, above its last closing price of $1.84.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 -0.17 -0.18 -0.18 Met 2.7
Jun. 30 2022 -0.24 -0.24 -0.23 Beat 4.2
Mar. 31 2022 -0.27 -0.27 -0.31 Missed -14.8
Dec. 31 2021 -0.24 -0.26 -0.23 Beat 11.5
Sep. -0.38 -0.36 -0.32 Beat 10.6
30 2021
Jun. 30 2021 -0.40 -0.41 -0.44 Missed -6.3
Mar. 31 2021 -0.53 -0.53 -0.49 Beat 7.5
Dec. 31 2020 -0.46 -0.46 -0.46 Met 0.4
This summary was machine generated March 3 at 14:06 GMT. All
figures in US dollars unless otherwise stated